Тиреотом

Quick links

Choose a section

Quick links to important sections

Advertisements

Тиреотом

Selected form

Advertisements
Advertisements
Advertisements

Overview of Тиреотом

Property Description
Active Ingredients Levothyroxine Sodium (L-T4) and Liothyronine (L-T3)
Form Oral Tablet
Pharmacological Class Thyroid Agents (Hormone replacement)
Common Use Restoring hormone levels to support normal metabolism
Origin Synthetic preparation

Тиреотом (Thyreotom) is a synthetic combination thyroid hormone replacement preparation supplied as an oral tablet for systemic administration. This drug is classified by the World Health Organization's Anatomical Therapeutic Chemical (ATC) system as a Thyroid Agent (ATC Code H03A), confirming its specialized role in substituting for hormones naturally produced by the thyroid gland. The preparation is specifically defined as a combination product because its formulation intentionally includes two distinct active ingredients, a feature recognized in clinical practice to address specific patient needs.

Composition: A Combination of Levothyroxine and Liothyronine

The core identity of this preparation rests on its dual composition: Levothyroxine Sodium (L-T4) and Liothyronine (L-T3). These compounds are the synthetic counterparts of the two main hormones produced by the thyroid gland. The inclusion of both L-T4 and L-T3 in a single product provides both the long-acting precursor hormone and the metabolically more potent, rapidly acting hormone. This dual approach utilizes the physiological roles of both hormones in maintaining euthyroid status.

General Purpose: Restoring Essential Metabolic Function

Тиреотом's central purpose is to provide replacement therapy to establish and maintain hormonal balance in individuals whose bodies do not produce enough thyroid hormones. By directly supplying the required T4 and T3 hormones, the preparation supports and normalizes the basal metabolic rate and influences protein synthesis across multiple body tissues. This action is essential for reversing the systemic symptoms associated with insufficient thyroid hormone levels, thereby helping to restore the patient's general physiological equilibrium. This medication is exclusively a synthetic preparation; its compounds are chemically manufactured to ensure consistency, a standard required for highly potent endocrine replacement therapies.

Regulatory References

  1. WHO Collaborating Centre for Drug Statistics Methodology
Advertisements

What side effects are possible with Тиреотом?

Possible Side Effects and Safety Information

The safety profile of Тиреотом (a combination thyroid hormone preparation) is primarily defined by the adverse reactions associated with hyperthyroidism, which occur mainly due to therapeutic overdosage, as documented in regulatory sources.


Official Adverse Reaction Groupings

The frequency of most adverse reactions is dose-dependent and typically not quantified in standard tables. However, effects are officially classified by the physiological systems they affect:

  • Cardiac Disorders: Tachycardia, palpitations, arrhythmias, and angina pectoris.
  • Nervous System Disorders: Headache, tremors, and nervousness.
  • Gastrointestinal Disorders: Diarrhea and abdominal cramps.
  • Metabolism and Nutrition: Increased appetite and weight loss.
  • General: Heat intolerance, excessive sweating, and fever.

Documented Serious Safety Risks

Official regulatory warnings highlight the potential for serious adverse reactions, particularly when over-treatment occurs. These include risks of myocardial infarction and worsening of congestive heart failure, especially in patients with pre-existing cardiovascular disease. The precipitation of Acute Adrenal Crisis is a noted risk if therapy is initiated in individuals with uncorrected adrenal insufficiency. Furthermore, long-term over-replacement is associated with a decrease in bone mineral density in post-menopausal women.


Safety Constraints and Special Populations

Тиреотом is formally contraindicated in individuals with untreated subclinical or overt thyrotoxicosis and in those with uncorrected adrenal insufficiency. Regulatory documents also highlight specific safety considerations for patient groups:

  • Elderly Patients: Have an increased risk of serious cardiac complications from over-treatment.
  • Pediatric Patients: Over-treatment may accelerate bone age maturation.
Advertisements

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory documents define the overdose profile for Тиреотом (Levothyroxine/Liothyronine) based on manifestations of thyrotoxicosis resulting from hormone excess. Overdosage is classified as capable of producing severe and life-threatening manifestations of toxicity.

Documented Overdose Manifestations

Symptoms may be delayed for several days after ingestion of the Levothyroxine component. Documented clinical signs often mimic hyperthyroidism, affecting multiple systems:

  • Cardiovascular: Palpitations, tachycardia (rapid heart rate), arrhythmias, and chest pain.
  • Central Nervous System (CNS): Nervousness, anxiety, headache, and tremors.
  • General/Metabolic: Excessive sweating, heat intolerance, fever, and weight loss.

Severe Outcomes and Emergency Action

Life-threatening outcomes documented in the prescribing information include myocardial infarction, cardiac arrest, and shock. Overdosage is particularly dangerous in the elderly and in patients with underlying cardiovascular disease.

Immediate medical attention is required for any suspected overdose. Patients must call emergency services or a poison control center right away, as mandated by regulatory guidance. No specific antidote is documented. Management is defined as symptomatic and supportive, often requiring continuous monitoring of vital signs and potential administration of supportive measures like activated charcoal.

Advertisements

Therapeutic Uses of Тиреотом

What Тиреотом treats: main uses and benefits

Тиреотом is a combination thyroid hormone replacement agent. The primary therapeutic domain is applied across areas where additional symptomatic support is needed in conditions characterized by periods of heightened symptoms due to hypothyroidism. This medication is commonly used to help with hypothyroidism and is also relevant for easing the symptoms of an enlarged thyroid gland, or goiter.

The medication is applied in addressing symptom clusters that may become intense or disruptive, such as symptoms related to systemic imbalance like fatigue, cold sensitivity, constipation, and depression. This provides support that helps ease the overall symptom burden and supports the patient during difficult episodes. It helps maintain a sense of stability when symptoms are more noticeable.

The use of Тиреотом may be part of symptomatic management in scenarios where additional management of discomfort is required. It assists with maintaining functional stability and generally contributes to improved day-to-day comfort during symptomatic periods.

Quick Fact: Relief for symptoms related to physical discomfort (e.g., muscle cramps, fatigue, and aches associated with hypothyroidism).

Regulatory References

  1. NIH MedlinePlus overview
Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Тиреотом?

This section outlines the official population eligibility and exclusion criteria for Тиреотом (a combination Levothyroxine and Liothyronine preparation), as defined by government regulatory documents.

Absolute Contraindications

Тиреотом must not be used in patients with the following conditions, as they represent absolute prohibitions:

  • Untreated Adrenal Cortical Insufficiency: Treatment must not begin until glucocorticoid replacement therapy is established.
  • Untreated Thyrotoxicosis (overt hyperthyroidism).
  • Acute Heart Conditions: Including acute myocardial infarction, acute myocarditis, or acute pancarditis.
  • Hypersensitivity: Known allergy to the active ingredients or excipients.
  • Obesity/Weight Loss: The drug is prohibited for treating obesity or promoting weight loss.

Restricted or Conditional Use

Population/Condition Restriction Requirement
Cardiovascular Disease Use with extreme caution; requires lower initial dosing and close monitoring for coronary artery disease and hypertension.
Older Adults (Geriatric) Requires lower starting doses due to higher risk of occult cardiac disease and atrial fibrillation.
Diabetes Mellitus Requires close monitoring and adjustment of anti-diabetic medications.
Pregnancy Not recommended for hypothyroidism; Levothyroxine monotherapy is the standard treatment.

Lactating women are generally permitted to use the drug at replacement doses.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Co-administration of Тиреотом (Levothyroxine Sodium and Liothyronine) with certain agents may result in pharmacokinetic or pharmacodynamic interactions that are officially documented in regulatory prescribing information.

Timing-Based Separation Requirements

The absorption of thyroid hormones can be reduced by physical binding in the gut. To prevent decreased exposure, agents such as Bile Acid Sequestrants (e.g., cholestyramine, colestipol) and Cation Exchange Resins must be administered at least four to five hours apart from Тиреотом. Similarly, Aluminium-containing Antacids, Iron Salts, and Calcium Salts require a separation of at least four hours.

Documented Pharmacodynamic and Exposure Alterations

Interacting Agent Category Officially Documented Interaction Outcome
Oral Anticoagulants (e.g., warfarin) May enhance the anticoagulant effect, increasing the risk of bleeding.
Antidiabetic Agents (e.g., insulin, metformin) May decrease the effectiveness of antidiabetic drugs, potentially increasing requirements.
Hepatic Enzyme Inducers (e.g., rifampicin, phenytoin) May increase the metabolic clearance of thyroid hormones, reducing plasma concentrations.
Oestrogen-Containing Products (e.g., oral contraceptives) Increase Thyroxine-Binding Globulin (TBG), decreasing the available free (active) hormone concentration.

Interactions with food and supplements include the reduced absorption of thyroid hormones by Dietary Fiber, Soy Products, and Grapefruit Juice, as specified in labeling.

Advertisements

Mechanism of Action

How Тиреотом Works


Nuclear Thyroid Hormone Receptor mathbf(TR) Agonism

This core mechanism involves the mathbfL -triiodothyronine (T3) component directly binding to and activating mathbfTR -alpha (TRalpha) and mathbfTR -beta (TRbeta) receptors within the cell nucleus. This engagement modifies mathbfgene transcription, initiating the synthesis of proteins essential for fundamental cellular processes and ultimately influencing the activity of pathways associated with mathbfsystemic metabolism.


Regulation of Cellular Energy Metabolism and Protein Synthesis

By modulating the expression of key metabolic enzymes and mathbfmitochondrial components, the drug engages mechanisms that influence the cell's rate of mathbfoxygen consumption and mathbfheat production. This action supports a regulated state within metabolic pathways, impacting the cellular rates of mathbfenergy production and utilization across the body.


Multi-Systemic Physiological Function Control

The mathbfT3-mediated transcriptional changes extend to specific tissues like the heart and central nervous system, where they modify the expression of mathbfmyosin isoforms and mathbfbeta -adrenergic receptors. This systemic influence modulates the activity of pathways involved in mathbfphysiological rate and rhythm, influencing mathbfcardiovascular and neurological processes via gene expression.

Advertisements

Dosage and Administration Information

Official Administration Guidelines for Thyrotom

Thyrotom is a combination thyroid hormone medicine (Levothyroxine/Liothyronine) intended for replacement therapy, and its use is governed by instructions to ensure proper dosing and absorption. The following guidelines are based on standard clinical parameters and prescribing data for combination thyroid hormones.

Administration Scope Official Instruction
Route & Form Administered orally as a tablet.
Frequency Taken once daily.
Timing & Meals Must be taken on an empty stomach in the morning, at least 30 minutes before breakfast.

Dosing and Titration Protocol

Dosing is highly individualized and must be determined and adjusted by a healthcare professional based on clinical status and monitoring of laboratory parameters, primarily serum Thyroid-Stimulating Hormone (TSH) levels.

Treatment is initiated at a low starting dose. Increases are made gradually and cautiously, typically in small increments every two to four weeks, until the appropriate maintenance dose is achieved. The therapy for hypothyroidism is generally lifelong.

Special Administration Conditions

  • Elderly and Cardiovascular Patients: These patients require a very low initial dose with extremely slow and cautious upward titration.
  • Pediatric Use: For infants, the tablet may be disintegrated in a small amount of water and administered immediately. This suspension must be freshly prepared just prior to intake.
  • Missed Dose: If a dose is missed, take it as soon as remembered unless it is nearly time for the next dose; in that case, skip the missed dose and resume the normal schedule. Do not take two doses at once.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Тиреотом

Evidence for Use in Hypothyroidism and Persistent Symptoms

Research has evaluated the Тиреотом (the L-T4 and L-T3 combination) in adults with hypothyroidism. The research has explored its study in patients reporting persistent outcomes related to systemic or functional imbalance (e.g., fatigue, changes in body weight, or difficulty with focus) even when Thyroid-Stimulating Hormone (TSH) levels are stable on standard L-T4 monotherapy.

To explore this, researchers used rigorous study designs, including numerous Randomized Controlled Trials (RCTs). Many of these were designed as double-blind, cross-over studies. Studies monitored patient-reported outcomes (PROs), which are applied in studies examining patient-reported experiences, specifically measuring Quality of Life (QoL), mood, and cognitive function scores.

Findings from these studies, which have been summarized in comprehensive Systematic Reviews and Meta-analyses, describe patterns observed in the studies related to how symptoms evolved in the observed populations. Some trials reported how patients ranked their experience on one regimen versus the other. However, when all the trial data is combined, the research so far indicates that the evidence related to outcomes reflecting daily functioning remains inconsistent across studies.


Long-Term Studies and Follow-Up Duration

Research has examined short-term comparison of L-T4/ L-T3 against L-T4 monotherapy, but the available evidence on long-term effects is limited. Follow-up durations were limited for many of the core comparative studies, and results apply only to the populations studied.

Consequently, long-term effects are not fully established, and research is ongoing. There is limited information for long-term outcomes, such as the maintenance of observed changes beyond the short-term trial windows, or the extended effects on heart health and bone density.


What is Still Uncertain About the Research for Тиреотом

The overall research landscape, synthesized by major reviews, describes several areas where long-term outcomes are not well characterized or where findings were mixed. One key limitation is the inconsistency of findings across different trials; what was observed in one study was not always replicated in another. Earlier trials often used L-T4 to L-T3 ratios that research describes as potentially sub-physiological, suggesting that the data for certain ratios may be insufficient.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Тиреотом (FAQ)


Q: Are there any foods or drinks that should be avoided when using Тиреотом?

Official administration instructions recommend taking this medicine on an empty stomach in the morning. To prevent reduced effectiveness, official drug-food interaction documents specify that substances such as grapefruit juice, soy products, and dietary fiber should be consumed separately from the medication. Adhering to the recommended time separation is described as important for maintaining consistent absorption, according to official administration guidelines.


Q: Does Тиреотом interact with common supplements like iron or calcium?

Yes, official documents specify that supplements containing high concentrations of Iron Salts and Calcium Salts may reduce the absorption of thyroid hormones in the digestive tract. To prevent this, these supplements must be administered at least four hours apart from Тиреотом.


Q: Can I take Тиреотом if I have no thyroid gland?

The primary purpose of Тиреотом is defined as thyroid hormone replacement therapy in official regulatory information. It is intended to substitute for the hormones that the body is not producing, such as after a total thyroidectomy (removal of the thyroid gland).


Q: Can stress or illness change how my body reacts to Тиреотом?

Official warnings note that stress or acute illness (such as an infection or surgery) may impact the body's response, particularly if underlying adrenal conditions exist. For instance, the medicine may also worsen diabetic control, requiring patients with diabetes to be monitored closely during periods of illness.


Q: Can children or adolescents use Тиреотом?

Yes, regulatory information indicates the drug is used in pediatric patients for acquired or congenital hypothyroidism. The official documents emphasize that dosing for this population is highly individualized and determined by a healthcare professional. Official safety information indicates that over-replacement in this population carries a risk of potentially accelerating bone age maturation.


Q: Can pregnant women safely use Тиреотом?

The combination preparation is not recommended for treating hypothyroidism during pregnancy, as Levothyroxine monotherapy is the established standard. Official prescribing information notes that untreated hypothyroidism during pregnancy is associated with risks. Hormone requirements for replacement therapy typically increase and require monitoring during this time.


Q: Does Тиреотом interact with blood thinning medications?

Yes, official regulatory documents describe that thyroid hormone preparations can enhance the effects of oral anticoagulants (often referred to as blood thinners), such as warfarin. Official documentation describes that, due to the increased risk of bleeding, careful monitoring may be required when these agents are used together.


Q: What are the less common, but serious, side effects of Тиреотом?

Serious risks associated with over-treatment are highlighted in official warnings. These include potential events like myocardial infarction (heart attack), the worsening of congestive heart failure, and precipitation of an acute adrenal crisis. Long-term use of an excessive dose is also associated with decreased bone mineral density, particularly in post-menopausal women.


Q: Does coffee or caffeine affect the absorption of Тиреотом?

Official instructions require taking the medicine on an empty stomach at least 30 minutes before breakfast. Although coffee is not always specifically named as an interacting agent, any substance other than water consumed during this required separation window may interfere with the drug's absorption.


Q: Is Тиреотом a natural thyroid medicine?

No, official regulatory documents define the active ingredients in this preparation, Levothyroxine and Liothyronine, as synthetic crystalline compounds. The drug is a chemically manufactured preparation to ensure consistency and reliable potency.


Q: How long does it usually take to notice an effect from Тиреотом?

Regulatory information for thyroid hormones indicates that the peak therapeutic effect of any dose change may not be fully apparent for approximately 4 to 6 weeks. For this reason, dosage changes and adjustments are typically made slowly and gradually.


Q: Is Тиреотом known to cause weight gain or weight loss?

The drug is officially prohibited from being used for the treatment of obesity or to promote weight loss in patients with normal thyroid function. However, the official side effect profile lists increased appetite and weight loss as effects associated with therapeutic overdosage (taking too high a dose).


Q: What happens if I accidentally miss a day of taking Тиреотом?

The official instruction for a missed dose is to take it as soon as it is remembered, unless it is nearly time for the next dose. If so, the missed dose should be skipped and the regular schedule resumed. Official guidance specifies that two doses should not be taken at once.


Q: Is Тиреотом safe for people who have heart problems?

Official warnings state that the drug must be used with extreme caution in patients with cardiovascular disease like coronary artery disease. Official warnings describe that patients with cardiovascular disease may require a very low initial dose and close monitoring due to an increased risk of serious cardiac adverse reactions.


Q: Can men and women use Тиреотом for the same conditions?

Yes, the indications for use (replacement therapy for hypothyroidism) are defined for the general population. Official documents include a specific warning for post-menopausal women concerning the risk of decreased bone mineral density if they receive a dose that is too high long-term.


Q: Can Тиреотом affect my sleep patterns?

Adverse reactions listed in official documents are primarily associated with overdosage (too high a dose). These effects on the central nervous system include symptoms such as nervousness, anxiety, irritability, and insomnia (difficulty sleeping).


Q: Are there specific times of the day when Тиреотом should be taken?

Official administration instructions specify taking the medicine as a single daily dose on an empty stomach. This should be done in the morning, between one-half to one hour before breakfast, to maintain consistent absorption as described in official guidelines.


Q: What are the signs that Тиреотом might not be working for me?

Official guidelines emphasize that inadequate treatment (meaning the drug is not fully working) can lead to the persistence of hypothyroidism symptoms. These symptoms often include persistent fatigue, cold intolerance, constipation, and difficulty with cognitive function.


Q: Does Тиреотом cause hair loss?

Official drug labeling often lists transient partial hair loss as an adverse reaction. This effect is most commonly observed in children and, occasionally, in adults during the first few months after starting therapy. This hair loss is usually temporary.


Q: Can I stop taking Тиреотом suddenly without problems?

The official prescribing information states that treatment for hypothyroidism is generally lifelong replacement therapy. Suddenly stopping the medicine may lead to the return of hypothyroid symptoms, as the body requires this external hormone supply.


Q: Is it possible to become dependent on Тиреотом?

The medication is defined as replacement therapy and is intended to supply hormones that the body can no longer produce sufficiently. For most patients with hypothyroidism, treatment is considered lifelong to maintain normal physiological function.


Q: What research themes are often discussed regarding Тиреотом and quality of life?

Research has often focused on assessing patient-reported outcomes (PROs) when comparing the combination therapy to standard treatment. Themes examined include scores for quality of life (QoL), mood, and cognitive function.


Q: Is Тиреотом used for non-thyroid health issues?

Official warnings state that the drug is strictly prohibited from use in patients who have normal thyroid function for the sole purpose of treating obesity or promoting weight loss.


Q: Can I take Тиреотом if I have diabetes?

Official documents describe that the medicine may worsen diabetic control or increase the requirements for antidiabetic agents (such as insulin or metformin). Official documents state that patients with diabetes may require close blood sugar monitoring and potential adjustment of their antidiabetic medications.


Q: Why might a patient switch from a T4-only medication to Тиреотом?

Research on the combination (T4/T3) therapy has often focused on patients who report persistent symptoms (such as fatigue, weight changes, or difficulty concentrating) even when their TSH levels are stable while on standard T4 monotherapy.


Q: Does Тиреотом interact with birth control pills?

Yes, official regulatory information specifies that oestrogen-containing products (like some birth control pills) can affect the medication. They can increase the blood level of Thyroxine-Binding Globulin (TBG), which may decrease the amount of free, active hormone available in the body.

Advertisements

How should Тиреотом be stored and disposed of?

How to Store and Dispose of Тиреотом

Official regulatory guidelines define strict storage and disposal requirements for this synthetic combination hormone product to ensure its stability and potency.

Requirement Area Official Rule
Temperature Store at or below 25 C (77 F), commonly known as Controlled Room Temperature.
Environmental Protection Keep the tablets protected from moisture and light, storing them in the original, tightly closed container.
Prohibited Conditions Do not refrigerate, freeze, or expose the product to high heat or humidity.
Child Safety The medicine must be kept out of the sight and reach of children.
Disposal Do not dispose of unused or expired tablets in household waste or wastewater; return them to a pharmacist for proper disposal according to local regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Тиреотом found in:

A-Z Index: